Relationship Between Facial Palsy and Psychological Distress
ConditionFacial Palsy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age25-50
SponsorCairo University
About this trial
The goal of this observational cross-sectional study is to investigate whether the severity of facial dysfunction is associated with psychological distress in patients with unilateral facial palsy.
The main questions it aims to answer are:
* Is there a significant relationship between the degree of facial muscle dysfunction (as measured by Sunnybrook Facial Grading Scale and EMG parameters) and levels of anxiety and depression (as measured by HADS)? * Does reduced facial function correlate with lower self-esteem levels (as measured by the Arabic version of the Single-Item Self-Esteem Scale)?
Researcher will assess and analyze the correlation between facial motor impairment and psychological outcomes to determine whether greater functional impairment is associated with increased psychological distress.
Participants will:
* Undergo clinical assessment using the Sunnybrook Facial Grading Scale to evaluate facial nerve function * Receive electrophysiological evaluation using surface electromyography (sEMG) to measure muscle activity * Complete standardized questionnaires including the Hospital Anxiety and Depression Scale (HADS) and the Arabic Single-Item Self-Esteem Scale (A-SISE)
Eligibility criteria
Qualifiers
Patients with unilateral idiopathic Bell's palsy confirmed by nerve conduction studies (NCS) will be included.
The age of patients ranged from 25 to 50 years.
The duration of Bell's palsy ranged from three months to two years.
Patients with a body mass index (BMI) less than 30 kg/m² will be included.
Disqualifiers
History of recurrent facial palsy or bilateral facial nerve involvement.
Presence of other neurological disorders unrelated to facial palsy affecting the face (e.g., stroke, multiple sclerosis).
A current diagnosis of psychiatric illness prior to the onset of facial palsy.
Cognitive impairment preventing valid completion of assessments.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov